National Review
By James Lynch
Health and Human Services Secretary Robert F. Kennedy Jr. said Wednesday the Food and Drug Administration should change the label on abortion drug mifepristone and conduct a top-to-bottom review of the pill after a new study showed the risks of serious side effects are greater than previously thought.